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The airway epithelial cell is an important target in ozone injury. Once activated, the airway epithelium responds in three phases. The initial, or imme-
diate phase, involves activation of constitutive cells, often through direct covalent interactions including the formation of secondary ozonolysis prod-
ucts-hydroxyhydroperoxides, aldehydes, and hydrogen peroxide. Recently, we found hydroxyhydroperoxides to be potent agonists of bioactive
eicosanoid formation by human airway epithelial cells in culture. Other probable immediate events include activation and inactivation of enzymes
present on the epithelial surface (e.g., neutral endopeptidase). During the next 2 to 24 hr, or early phase, epithelial cells respond by synthesis and
release of chemotactic factors, including chemokines-macrophage inflammatory protein-2, RANTES, and interleukin-8. Infiltrating leukocytes during
this period also release elastase, an important agonist of epithelial cell mucus secretion and additional chemokine formation. The third (late) phase of
ozone injury is characterized by eosinophil or monocyte infiltration. Cytokine expression leads to alteration of structural protein synthesis, with
increases in fibronectin evident by in situ hybridization. Synthesis of epithelial antiproteases, e.g., secretary leukocyte protease inhibitor, may also
increase locally 24 to 48 hr after elastase concentrations become excessive. Thus, the epithelium is not merely a passive barrier to ozone injury but
has a dynamic role in directing the migration, activating, and then counteracting inflammatory cells. Through these complex interactions, epithelial
cells can be viewed as the initiators (alpha) and the receptors (omega) of ozone-induced airway disease. - Environ Health Perspect 103
(Suppl 2):91-95 (1995)
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Introduction
Concerns continue to increase about
whether the current ambient air quality
standard for ozone (120 ppb) provides an
adequate margin ofsafety for the U.S. pop-
ulation. Several clinical (1-4) and epi-
demiological (5-7) studies, some ofwhich
are presented in detail in this paper, have
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documented significant decrements in pul-
monary airflow in persons exposed to
< 120 ppb (Table 1). Such effects are more
readily observed in exercising individuals
when exposures are extended (>4 hr) (8).
In related studies, another consistent
finding is an increase in inflammatory cells
in bronchoalveolar lavage fluid obtained
after <120 ppb ozone exposure (1,3,4).
Increases in inflammatory mediators
(bioactive lipids and cytokines) and pro-
tease (elastase) accompany this change
(Figure 1). The cellular sources of these
mediators in bronchoalveolar lavage fluid
from proximal conducting airway and dis-
tal lung regions are uncertain.
Although the bronchoalveolar junction
is considered the primary site of ozone
attack in the lung (9), another important
target site is the airway epithelium (10).
Previous analyses ofregional ozone deposi-
tion and absorption (11,12) suggest that
exposure to high concentrations of ozone
could result in deposition sufficient to
induce epithelial damage (histological
changes). Such ozone exposure can alter the
maintenance of epithelial barrier (13-15)
and particle clearance function (16).
However, at lower concentrations (i.e.,
-100 ppb), ozone deposition in the airways
is likely to be less, and health effects are
thus more difficult to uncover experimen-
tally. Nonetheless, the apparent changes in
airway function (e.g., decreased forced expi-
ratory volume [FEV10]) argues that airway
perturbation (perhaps at a level undetected
by conventional histology) must occur even
at lowlevel exposure.
Subtle injury to epithelial cells may play
an active role in systemic airway responses
following low-level ozone exposure
(5,17,18). In evaluating these effects, it is
important to consider both constitutive
functions and elicited defense mechanisms
of the epithelium (Table 2). Ozone may
influence cellular function directly by chem-
ical modification of molecular constituents
of the cell membrane or indirectly by the
interaction of its primary reaction products
Table 1. Pulmonary response to ozone.
Decreased forced expiratory volume -1.0 (FEV1 )a
Airwayhyperreactivitya
Airway inflammation
Decreased athletic performance8
Increased cough and symptoms (substernal discomfort,
etc.)a
Altered tracheobronchial clearance
Increased epithelial permeability
aOccur at or below current National Air Quality Standard
of 120 ppb.
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Figure 1. Abbreviations: ND, not done, PGE2,
prostaglandin E Increases in inflammatory cells, pro-
teins, and mediators measured in bronchoalveolar
lavage fluid obtained from persons exposed for 6.6 hr
to 400 ppb (hatched bars) or 100 ppb (open bars) ozone.
Adapted from Delvin et al. (4).
Table 2. Constitutive and elicited defense mecha-
nisms ofthe airway epithelium.
A. Constitutive function
1. Mucus synthesis and secretion
2. Ciliary clearance
3. Ion transport and fluid movement
4. Biotransformation
a. Neutral endopeptidase
b. Cytochrome P450 (lAl)
5. Antiinflammatory activity
a. Eicosanoids (PGE2)
B. Elicited defense mechanisms
1. Antiprotease
a. Secretory leukocyte protease inhibitor
2. Antioxidant
a. Superoxide dismutase (SoxR)
b. Catalase (OxyR)
3. Antimicrobial
a. Lysozyme
with the cell. Although the anatomical, cel-
lular, and biochemical sites of reaction of
ozone in the lungs are not known, it is gen-
erally believed that ozone does not penetrate
further than the airway epithelium because
of its high reactivity (19). This would con-
fine ozone to react with substances in the
extracellular fluid in the airway lumen and
in the apical plasma membrane of the
epithelial cell. The resultant ozonolysis
products are generally more stable than
ozone itself and can diffuse farther into the
airway epithelium, where they may activate
one or more mediator cascades and thereby
elicit avariety ofcellular responses. Here, we
divide the likely events associated with
ozone injury to the airway epithelium into
immediate, early, and late phases (Table 3).
Immediate Phase
The immediate phase occurs during (or
within 2 hr after) exposure and is charac-
Table 3. Time-course of responses to injury in the air-
way epithelium.
A. Immediate responses (0-2 hr) (constitutive cell
activation)
1. Chemical reaction with membrane
2. Biotransformation
a. Cytochrome P450
b. Neutral endopeptidase
3. Bioactive lipid release
a. Eicosanoids
b. Platelet-activating factor
4. Sensory neuro-reflex pathways
B. Early responses (2-24 hr) (neutrophil infiltration)
1. Bioactive lipid release
2. Proinflammatory mediator release (neutrophil
chemotaxins)
3.Antiinflammatory mediator release(prostanoids)
4. Cytokine release
a. Tumor necrosis factor-ac
b. Interleukins (IL-1, IL-6, IL-8, etc.)
5. Protease release
a. Elastasea
b. Cathepsin Ga
C. Late responses (12-24 hr) (eosinophil/monocyte
infiltration
1. Bioactive lipid release
a. Increases in proinflammatory (monocyte
chemotaxins)
b. Decreases in anti-inflammatory (prostanoids)
2. Cytokine release
a. Granulocyte, macrophage-colony stimulating
factor (eosinophil proliferation)
b. Transforming growth factor-,B
c. Platelet-derived growth factor
3. Intercellular adhesion molecules
4. Structural proteins synthesis
a. Collagen
b. Fibronectin
5. Major basic protein (from eosinophilic infiltration)a
6. Antiprotease synthesis and release
a. Secretory leukocyte protease inhibitor
7. Antioxidants synthesis
a. Superoxide dismutase
b. Catalase
c. Glutathione
aNot produced (or yet not confirmed) by human airway
epithelial cells. All others can be synthesized by and
released fromairwayepithelial cells.
terized by activation of constitutive cells
in the airway epithelium. Because it is a
highly reactant irritant (20), ozone's
attack may be limited to components of
the respiratory tract fluid and the apical
plasma membrane, with little unreacted
ozone penetrating into the cytosol (19).
Examination of ozone reactions with
amino acids (21,22), proteins (23-28),
unsaturated fatty acids (29-31), and
phospholipids containing fatty acids
(32-35) in vitro indicates that ozone is
likely to react with cysteine, methionine,
tyrosine, tryptophan, and histidine
residues in proteins and carbon-carbon
double bonds ofunsaturated fatty acids in
membrane lipids (Figure 2). The latter
reactions yield hydrogen peroxide,
aliphatic and allelic aldehydes and
hydroxyhydroperoxides of various chain
lengths (32,35).
Recently, we have investigated the ability
ofselected ozonolysis products offatty acids
to activate membrane phospholipases in
human airwayepithelial cells in culture (36).
Compounds with longer chain lengths were
more potent than compounds of shorter
chain length (C9 >C6 >C3), and hydroxyhy-
droperoxides were more potent than corre-
sponding aldehydes or hydrogen peroxide in
initiating eicosanoid release from human air-
way epithelial cells. Significant effects were
observed at concentrations of .3 pM 1-
hydroxy-I-nonanehydroperoxide.
To place these findings into perspective
with regard to in vivo exposure concentra-
tion, we estimate the rate of hydroxyhy-
droperoxide production at the airway sur-
face based on available estimates of ozone
deposition in the lung. Many difficulties
are associated with such an estimate, so an
initial point is to apply the dosimetric
model developed by Miller and Overton
(11,12) that predicts a dose of up to
approximately 2 pg 03 deposited/cm tis-
suex min per pg ambient 03/m3 air. This
value can be higher or lower, depending
on breathing rate and site of regional
deposition, respectively. At an ambient
concentration of 120 ppb (2.4x108
pg/mi3 air: the current ambient air quality
standard), the rate of adsorption of ozone
by the airway epithelium would be 10
pmole/cm2xmin (480 pg/cm2xmin÷48
pg/pmole) From the stoichiometry of the
reaction, we know that 1 molecule of
hydroxyhydroperoxide will be produced
from every molecule of ozone that reacts
with a carbon-carbon double bond in an
unsaturated fatty acid. If we limit the
amount of ozone that reacts with unsatu-
rated fatty acids to 20% of the absorbed
dose, then the hydroxyhydroperoxides for-
mation rate would be approximately
2 pmole/cm2xmin. Assuming these prod-
ucts remain within a 10 pm layer on the
airway surface, the concentration of
hydroxyhydroperoxide is approximately
equal to the lowest dose (3 ,uM) that elicit-
ed [3H]-activity release from airway
epithelial cells.
These findings suggest that secondary
ozonolysis products also have biological
activity. Because they are more stable than
ozone, these compounds can move from
their formation site and react within the
cytoplasm, activating other enzymes (e.g.,
cyclooxygenase). Thus, inhaled ozone can
generate chemical intermediates that can
react with and activate epithelial cells.
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Figure 2. Possible reaction sites of ozone with cellular macromolecules. The three preferred sites are free
sulfhydryl groups in membrane proteins, carbon-carbon double bonds in unsaturated fatty acids, and disulfide
crosslinks in membrane proteins. Ozonolysis of membrane fatty acids leads to the formation of an aldehyde and a
hydroxyhydroperoxide, one retained in the membrane the other free to exist the membrane and react with cyto-
plasmic constituents. When a hydroxyhydroperoxide is formed, it subsequently reacts in the presence of water to
form a second aldehyde and hydrogen peroxide (H202). Thus, the net reactions yield two aldehydes andH202'
In addition to immediate activation of
phospholipases (responsible for arachidonic
acid release and subsequent metabolism by
specific pathways), ozone could possibly
alter other enzymes responsible for bio-
transformation capacity within the epithe-
lium. Again, this could result from direct
ozone reactions with amino acid in mem-
brane-bound proteins (24,28) or through
the action ofreactive intermediates (such as
hydroxyhydroperoxides) that can act at
sites distant (cytoplasmic, nucleus) to the
site of initial ozonolysis (35). Thus both
surface and nonmembrane-bound proteins
and enzymes could be activated or inacti-
vate by ozone exposure.
The biological consequences of other
inhaled materials, when absorbed subse-
quently, can also be influenced by this
process because they can be activated by
epithelial enzymes (e.g., aromatic hydro-
carbon by cytochrome P4 ) or inactivated
by other enzymes, (e.g.,Mehydes by alde-
hyde dehydrogenases). Thus, alteration in
constitutive "metabolic" functions within
the epithelial cell may affect local response
to subsequent stimuli. Experimental
details are yet to be obtained with ozone
in this area, this may be a fertile subject
for further research.
An example of inactivation/activation
ofepithelial enzymes has been clarified fol-
lowing toluene diisocyanate inhalation.
This irritant can inactivate neutral
endopeptidase, contained on the plasma
membrane surface of airway basal cells.
Loss of neutral endopeptidase can in turn
heighten airway smooth muscle reactivity
to substance P and other neuropeptides
(37). Similarly, loss of neutral endopepti-
dase activity caused by toluene diisocyanate
may influence subsequent responses to irri-
tants such as compounds that induce
mucosal edema or mucus gland secretion
(through mechanisms involving retrograde
neurotransmitter release from sensory neu-
rons). Data on ozone's effects on this
important enzyme are preliminary (38,39),
but recent evidence suggest that neuropep-
tide release and inactivation of neutral
endopeptidase can also occur following
ozone exposure.
Early Phase
During 2 to 24 hr after acute injury, the
next (early) phase is initiated and charac-
terized by infiltration of polymorphonu-
clear leukocytes (predominately neu-
trophils). Epithelial cells, along with other
resident cells, can synthesize and release
chemotactic factors thereby directing
migration and activation of neutrophils
(17,40,41). This, in part, results from aug-
mented bioactive lipid mediator release
from both resident and migratory cells,
with elevations present in pro-inflammato-
ry eicosanoid (e.g., leukotriene B4 or
prostaglandin F2Q). As noted previously,
ozone activates eicosanoid metabolism in
airway epithelial cells (17,36).
Additional elevations of cytokine con-
centrations, demonstrated to be derived
from airway epithelial cells, may also play
an important role in orchestrating this early
response to ozone. Elevated synthesis and
release of interleukins (IL) and possibly
tumor necrosis factor (TNF ) during this
early period are thought to activate the sub-
sequent release ofsecondary mediators. For
example, IL-1 and TNFa may be responsi-
ble for secondary IL-6 and IL-8 expression.
Recently, we have begun to examine the
effects of ozone inhalation on macrophage
inflammatory protein-2 (MIP-2), a
chemokine, in mouse lung (42). These
results indicate that MIP-2 mRNA tran-
script levels are increased (as determined by
reverse transcription-polymerase chain
reaction) at doses that produce increases in
neutrophils in lavage fluid. Increases in
MIP-2 transcript levels also precede the
neutrophil infiltration. Our initial conclu-
sion is that ozone-induced chemokine
(including MIP-2 and related proteins, IL-
8, RANTES, etc.) expression has a clearer
association with neutrophil infiltration than
does chemotactic eicosanoid (leukotriene
B4 or 15-diHETE) formation.
Once leukocytes are present, the profile
of eicosanoid metabolites within the
epithelium also may change through tran-
scellular eicosanoid metabolism. For exam-
ple, leukotriene A4 (LTA ) released from
activated neutrophils can be subsequently
metabolized to leukotriene B (LTB4) by
adjacent cells. Recently, we ave begun
examining transcellular metabolism with
airway cells and neutrophils stimulated
with Ca-ionophore, a stimulus ofphospho-
lipase. Leukotriene B4 production is
increased when cells are cocultured. Since
ozone also stimulates phospholipase, it is
likely that it could also affect LTA4-LTB4
co-metabolism.
Finally, during this period, elastase and
cathepsin G can be released from incoming
cells. Neutrophil elastase is clearly elevated
in bronchoalveolar lavage in persons
exposed to ozone (Figure 1). Elastase is a
potent agonist for mucus secretion (43)
and chemokine formation (41).
Late Phase
The third phase ofozone injury is charac-
terized by a period of eosinophil (impor-
tant in asthma) or monocyte (important in
bronchitis) infiltration. Clear alterations in
DNA transcription, steady-state mRNA
levels, and protein synthesis are likely to
occur during this period. Proinflammatory
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eicosanoid (and possibly cytokine) synthe-
sis in the epithelium continues during this
period, with release of additional mono-
cyte chemotaxins (44), and possibly gran-
ulocyte, macrophage-colony stimulating
factor (45,46) or transforming growth
factory (47-49).
During this time, factors like trans-
forming growth factor- may markedly
enhance fibronectin mRNA expression. In
human airway epithelial cells, as evidenced
by cells in culture, TGF -induced
fibronectin mRNA expression can increase
with a time course consistent with a late
phase response (maximal levels occur after
18 to 24 hr). Synthesis ofother structural
proteins (important in tissue repair),
antiproteases (including secretary leuko-
cyte protease inhibitor) (50), and antioxi-
dants (superoxide dismutase, catalase and
glutathione reductase) (51) also increase
during this period. The loss ofanti-inflam-
matory eicosanoids through suicidal,
cyclooxygenase inactivation may aggravate
leukocyte activation, protease release, and
tissue damage. Clearly several ofthese pos-
sibilities merit further investigation.
Summary
Inhalation of ozone in the past has been
associated with airway dysfunction
marked by physiologic and histological
change. These changes are typically noted
only after high level exposure. More sub-
tle changes have been noted in recent
years which may or may not be associated
with histological changes. Through a
clearer understanding ofozone's preferred
targets and the role ofsubtle biochemical
changes in the airway epithelium, the
early events in a host-initiated cascade
have been uncovered. At present, aspects
ofthe above discussion are still speculative
due to a lack ofexperimental details. (For
example, does the increase in MIP-2
observed in mouse lung occur in
humans?) One purpose of this presenta-
tion is to present future research direc-
tions that may increase our knowledge of
the cellular and subcellular mechanisms
responsible for ozone toxicity.
Nonetheless, at present we can con-
clude that epithelium is not passive in air-
way injury/response to ozone. It has an
active role in directing the migration of
inflammatory cells and in the release and
co-metabolism of inflammatory mediators.
Thus, it is partially responsible for changes
in the microenvironment surrounding the
epithelial cells. Ultimately, these changes
can alter the phenotype of the epithelial
cell population, possibly leading to persis-
tent changes in cell metabolism (e.g., loss
ofneutral endopeptidase) or in mucin-pro-
ducing cell types important in hypersecre-
tory diseases (bronchitis). In this way,
epithelial cells can be viewed as the alpha
(initiator) and the omega (receptor) cell in
ozone-induced airway disease.
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